Connect Sign In
0061164
Lactoferrin, Fecal by ELISA
FECLACTO
Ordering Recommendation
May be used to screen for inflammatory bowel disease (IBD) versus irritable bowel syndrome (IBS).
New York DOH Approval Status
This test is New York state approved.
Specimen Required
Patient Preparation
Collect
Stool.
Specimen Preparation
Transfer 5 g stool to an unpreserved stool transport vial (ARUP supply #40910). Available online through eSupply using ARUP Connect(TM)or contact Client Services at 800-522-2787. (Min: 1 g)
Storage/Transport Temperature
Refrigerated.
Unacceptable Conditions
Specimens in any transport media.
Remarks
Stability
Ambient: 2 weeks; Refrigerated: 2 weeks; Frozen: 2 weeks
Methodology
Qualitative Enzyme-Linked Immunosorbent Assay (ELISA)
Performed
Sun-Sat
Reported
1-2 days
Reference Interval
| Test Number |
Components |
Reference Interval |
|---|---|---|
| Lactoferrin, Fecal by ELISA | Negative |
Interpretive Data
A positive result is indicative of the presence of lactoferrin, a marker for fecal leukocytes. A negative result does not exclude the presence of intestinal inflammation.
Compliance Category
FDA
Note
Hotline History
Hotline History
Date of Change
Test Name Change
Methodology
Performance/Reported Schedule
Specimen Requirements
Reference Interval
Interpretive Data
Note
CPT Code
Component Change
Other Interface Change
New Test
Inactive
N/A
CPT Codes
83630
Components
| Component Test Code* | Component Chart Name | LOINC |
|---|---|---|
| 0061164 | Lactoferrin, Fecal by ELISA | 40703-1 |
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
Aliases
- Fecal Lactoferrin
- Fecal Leukocytes
- Fecal WBC Non-microscopic
- Stool Lactoferrin
Lactoferrin, Fecal by ELISA
